T-cell-depleted peripheral blood stem cell transplantation for α-mannosidosis

Bone Marrow Transplantation

Volumn 32, Issue 4, 2003, Pages 443-446

  Albert, M H ^a   Schuster, F ^a   Peters, C ^b   Schulze, S ^a   Pontz, B F ^c   Muntau, A C ^a   Roschinger W ^a   Stachel, D K ^d   Enders, A ^a   Haas, R J ^a   Schmid, I ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

mannosidosis; CD34 positive selection; Lysosomal storage disease; Peripheral blood stem cell transplantation

Indexed keywords

ALPHA MANNOSIDASE; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; OKT 3; OLIGOSACCHARIDE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LYMPHOCYTE DEPLETION; MALE; MANNOSIDOSIS; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ALPHA-MANNOSIDOSIS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD34; BONE AND BONES; BUSULFAN; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INFANT; LYMPHOCYTE DEPLETION; MALE; METHYLPREDNISOLONE; MUROMONAB-CD3; OLIGOSACCHARIDES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHENOTYPE; T-LYMPHOCYTES; TIME FACTORS;

EID: 10744221733     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704148     Document Type: Article

References (18)

1. Michalski JC, Klein A. Glycoprotein lysosomal storage disorders: α- and β-mannosidosis, fucosidosis and α-N-acetylgalactosaminidase deficiency. Biochim Biophys Acta 1999; 1455: 69-84.
2. Wall DA, Grange DK, Goulding P et al. Bone marrow transplantation for the treatment of α-mannosidosis. J Pediatr 1998; 133: 282-285.
3. Sun H, Wolfe JH. Recent progress in lysosomal alpha-mannosidase and its deficiency. Exp Mol Med 2001; 33: 1-7.
4. Autio S, Louhimo T, Helenius M. The clinical course of mannosidosis. Ann Clin Res 1982; 14: 93-97.
5. Malm D, Halvorsen DS, Tranebjaerg L, Sjursen H. Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. Eur J Pediatr 2000; 159: 699-703.
6. Wraith JE. Advances in the treatment of lysosomal storage disease. Dev Med Child Neurol 2001; 43: 639-646.
7. Eng CM, Guffon N, Wilcox WR et al. Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 9-16.
8. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartyl-glucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999; 12: 167-176.
9. Walkley SU, Thrall MA, Dobrenis K et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA 1994; 91: 2970-2974.
10. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239: 290-292.
11. Will A, Cooper A, Hatton C et al. Bone marrow transplantation in the treatment of α-mannosidosis. Arch Dis Child 1987; 62: 1044-1049.
12. Sewell AC. An improved thin-layer chromatography method for urinary oligosaccharide screening. Clin Chim Acta 1979; 92: 411-414.
13. Tellegen PJ, Laros JA. The construction and validation of a nonverbal test of intelligence: the revision of the Snijders-Oomen tests. Eur J Psychol Assess 1993; 9: 147-157.
14. Wallkley SU, Dobrenis K. Bone marrow transplantation for lysosomal diseases. Lancet 1995; 345: 1382-1383.
15. Albert M, Schuster F, Schulze S et al. Low dose donor lymphocyte infusions (DLI) promote donor chimerism after T-cell depleted PBSCT but do not prevent leukemia relapse. Bone Marrow Transplant 2002; 30 (Suppl. 3): 108.
16. +-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases. Bone Marrow Transplant 2001; 29: 9-13.
17. Peters C, Shapiro EG, Anderson J et al. Hurler syndrome: II, Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty four children. Blood 1998; 91: 2601-2608.
18. Sun H, Yang M, Haskins ME. Retrovirus vector-mediated correction and cross-correction of lysosomal alpha-mannosidase deficiency in human and feline fibroblasts. Hum Gene Ther 1999; 10: 1311-1319.